Mithra Pharmaceuticals SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 7.04 million compared to EUR 11.36 million a year ago. Net loss was EUR 50.47 million compared to EUR 31.25 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.216 EUR | -1.82% | -.--% | -82.78% |
04-29 | Mithra Pharmaceuticals to Postpone the Publication of Its Annual Report 2023 | CI |
04-22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-82.78% | 16.04M | |
-3.68% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+53.68% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-6.20% | 8.3B |
- Stock Market
- Equities
- MITRA Stock
- News Mithra Pharmaceuticals S.A.
- Mithra Pharmaceuticals SA Reports Earnings Results for the Half Year Ended June 30, 2023